114 related articles for article (PubMed ID: 17328228)
1. Glucosidase inhibitors as antiviral agents for hepatitis B and C.
Durantel D; Alotte C; Zoulim F
Curr Opin Investig Drugs; 2007 Feb; 8(2):125-9. PubMed ID: 17328228
[TBL] [Abstract][Full Text] [Related]
2. The role of antiviral agents in the management of viral hepatitis.
Mutimer D
Clin Med (Lond); 2006; 6(1):29-34. PubMed ID: 16521353
[No Abstract] [Full Text] [Related]
3. The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases.
Mohammadi Pour P; Fakhri S; Asgary S; Farzaei MH; Echeverría J
Front Pharmacol; 2019; 10():1207. PubMed ID: 31787892
[TBL] [Abstract][Full Text] [Related]
4. Drug targets in hepatitis B virus infection.
Stein LL; Loomba R
Infect Disord Drug Targets; 2009 Apr; 9(2):105-16. PubMed ID: 19275699
[TBL] [Abstract][Full Text] [Related]
5. An Update on SARS-CoV-2 Clinical Trial Results-What We Can Learn for the Next Pandemic.
Arman BY; Brun J; Hill ML; Zitzmann N; von Delft A
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203525
[TBL] [Abstract][Full Text] [Related]
6. Deciphering Molecular Aspects of Potential
Elhady SS; Alshobaki NM; Elfaky MA; Koshak AE; Alharbi M; Abdelhameed RFA; Darwish KM
Metabolites; 2023 Aug; 13(8):. PubMed ID: 37623885
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, biological evaluation, and molecular modeling studies of pyrazole-benzofuran hybrids as new α-glucosidase inhibitor.
Azimi F; Azizian H; Najafi M; Khodarahmi G; Saghaei L; Hassanzadeh M; Ghasemi JB; Faramarzi MA; Larijani B; Hassanzadeh F; Mahdavi M
Sci Rep; 2021 Oct; 11(1):20776. PubMed ID: 34675367
[TBL] [Abstract][Full Text] [Related]
8. Green synthesis of 1,5-dideoxy-1,5-imino-ribitol and 1,5-dideoxy-1,5-imino-DL-arabinitol from natural D-sugars over Au/Al
Gao H; Fan A
Sci Rep; 2021 Aug; 11(1):16928. PubMed ID: 34413372
[TBL] [Abstract][Full Text] [Related]
9. Application 2D Descriptors and Artificial Neural Networks for Beta-Glucosidase Inhibitors Screening.
Przybyłek M
Molecules; 2020 Dec; 25(24):. PubMed ID: 33333961
[TBL] [Abstract][Full Text] [Related]
10. Iminosugars: A host-targeted approach to combat Flaviviridae infections.
Evans DeWald L; Starr C; Butters T; Treston A; Warfield KL
Antiviral Res; 2020 Dec; 184():104881. PubMed ID: 32768411
[TBL] [Abstract][Full Text] [Related]
11. Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus Infection.
Xia Y; Liang TJ
Gastroenterology; 2019 Jan; 156(2):311-324. PubMed ID: 30243618
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatitis B virus: an update.
Ward H; Tang L; Poonia B; Kottilil S
Future Microbiol; 2016 Dec; 11(12):1581-1597. PubMed ID: 27855500
[TBL] [Abstract][Full Text] [Related]
13. DenHunt - A Comprehensive Database of the Intricate Network of Dengue-Human Interactions.
Karyala P; Metri R; Bathula C; Yelamanchi SK; Sahoo L; Arjunan S; Sastri NP; Chandra N
PLoS Negl Trop Dis; 2016 Sep; 10(9):e0004965. PubMed ID: 27618709
[TBL] [Abstract][Full Text] [Related]
14. Enantioselective synthesis of polyhydroxyindolizidinone and quinolizidinone derivatives from a common precursor.
Saha N; Chattopadhyay SK
Beilstein J Org Chem; 2014; 10():3104-10. PubMed ID: 25670979
[TBL] [Abstract][Full Text] [Related]
15. Emerging structural insights into glycoprotein quality control coupled with N-glycan processing in the endoplasmic reticulum.
Satoh T; Yamaguchi T; Kato K
Molecules; 2015 Jan; 20(2):2475-91. PubMed ID: 25647580
[TBL] [Abstract][Full Text] [Related]
16. Strategies to eliminate HBV infection.
Kapoor R; Kottilil S
Future Virol; 2014; 9(6):565-585. PubMed ID: 25309617
[TBL] [Abstract][Full Text] [Related]
17. Bitter-sweet symphony: glycan-lectin interactions in virus biology.
Van Breedam W; Pöhlmann S; Favoreel HW; de Groot RJ; Nauwynck HJ
FEMS Microbiol Rev; 2014 Jul; 38(4):598-632. PubMed ID: 24188132
[TBL] [Abstract][Full Text] [Related]
18. Specificity of Processing α-glucosidase I is guided by the substrate conformation: crystallographic and in silico studies.
Barker MK; Rose DR
J Biol Chem; 2013 May; 288(19):13563-74. PubMed ID: 23536181
[TBL] [Abstract][Full Text] [Related]
19. Antiviral therapy for hepatitis C virus: beyond the standard of care.
Delang L; Coelmont L; Neyts J
Viruses; 2010 Apr; 2(4):826-866. PubMed ID: 21994657
[TBL] [Abstract][Full Text] [Related]
20. New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents.
Quer J; Buti M; Cubero M; Guardia J; Esteban R; Esteban JI
Infect Drug Resist; 2010; 3():133-45. PubMed ID: 21694902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
